Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatitis, Atopic | 55 | 2023 | 654 | 9.180 |
Why?
|
Peanut Hypersensitivity | 19 | 2023 | 163 | 3.410 |
Why?
|
Eczema | 12 | 2023 | 231 | 2.850 |
Why?
|
Desensitization, Immunologic | 21 | 2023 | 483 | 2.720 |
Why?
|
Food Hypersensitivity | 22 | 2022 | 622 | 2.580 |
Why?
|
Allergens | 24 | 2023 | 1320 | 1.580 |
Why?
|
Dermatologic Agents | 4 | 2023 | 278 | 1.420 |
Why?
|
Anti-Allergic Agents | 6 | 2018 | 141 | 1.390 |
Why?
|
Kaposi Varicelliform Eruption | 12 | 2021 | 47 | 1.350 |
Why?
|
Immunoglobulin E | 30 | 2023 | 1463 | 1.190 |
Why?
|
Asthma | 23 | 2023 | 6011 | 1.180 |
Why?
|
Anaphylaxis | 13 | 2023 | 746 | 1.160 |
Why?
|
Pruritus | 5 | 2023 | 361 | 0.820 |
Why?
|
Antibodies, Anti-Idiotypic | 5 | 2018 | 349 | 0.820 |
Why?
|
Complement C1 Inhibitor Protein | 4 | 2015 | 97 | 0.730 |
Why?
|
Skin Tests | 15 | 2017 | 613 | 0.710 |
Why?
|
Egg Hypersensitivity | 5 | 2017 | 44 | 0.710 |
Why?
|
Angioedemas, Hereditary | 4 | 2015 | 91 | 0.700 |
Why?
|
Hypersensitivity | 6 | 2023 | 1102 | 0.660 |
Why?
|
Nut Hypersensitivity | 3 | 2013 | 23 | 0.660 |
Why?
|
Tacrolimus | 3 | 2023 | 743 | 0.640 |
Why?
|
Adrenal Cortex Hormones | 7 | 2023 | 1855 | 0.620 |
Why?
|
Immunologic Deficiency Syndromes | 8 | 2013 | 547 | 0.610 |
Why?
|
Patient Education as Topic | 5 | 2021 | 2278 | 0.590 |
Why?
|
Sesamum | 3 | 2013 | 16 | 0.590 |
Why?
|
Immunoglobulins, Intravenous | 6 | 2006 | 652 | 0.560 |
Why?
|
Hypersensitivity, Immediate | 5 | 2018 | 337 | 0.540 |
Why?
|
Child | 83 | 2023 | 77709 | 0.540 |
Why?
|
Teaching Materials | 1 | 2016 | 86 | 0.530 |
Why?
|
Urticaria | 3 | 2019 | 150 | 0.520 |
Why?
|
Histamine Antagonists | 1 | 2014 | 93 | 0.470 |
Why?
|
Child, Preschool | 49 | 2023 | 41006 | 0.430 |
Why?
|
Complement Inactivating Agents | 1 | 2012 | 50 | 0.430 |
Why?
|
Insect Bites and Stings | 2 | 2018 | 67 | 0.390 |
Why?
|
Chickenpox Vaccine | 1 | 2010 | 79 | 0.380 |
Why?
|
Agammaglobulinemia | 2 | 2011 | 167 | 0.370 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 9 | 2017 | 62 | 0.370 |
Why?
|
Herpesviridae Infections | 2 | 2010 | 277 | 0.350 |
Why?
|
Herpesvirus 3, Human | 1 | 2010 | 204 | 0.350 |
Why?
|
Interferon-gamma | 11 | 2015 | 3206 | 0.350 |
Why?
|
Respiratory Tract Infections | 5 | 2000 | 961 | 0.340 |
Why?
|
Humans | 149 | 2023 | 744343 | 0.340 |
Why?
|
Angioedema | 2 | 2008 | 187 | 0.340 |
Why?
|
Infant | 33 | 2023 | 35136 | 0.330 |
Why?
|
Adolescent | 56 | 2023 | 85781 | 0.320 |
Why?
|
Cold Temperature | 2 | 2018 | 772 | 0.310 |
Why?
|
Common Variable Immunodeficiency | 4 | 2007 | 93 | 0.310 |
Why?
|
Parents | 3 | 2022 | 3407 | 0.310 |
Why?
|
Immunoglobulin G | 6 | 2021 | 4560 | 0.310 |
Why?
|
Influenza Vaccines | 2 | 2017 | 738 | 0.300 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2006 | 13 | 0.290 |
Why?
|
Severity of Illness Index | 11 | 2023 | 15540 | 0.290 |
Why?
|
Milk Hypersensitivity | 3 | 2012 | 76 | 0.290 |
Why?
|
Interleukin-4 | 7 | 2019 | 1147 | 0.280 |
Why?
|
Patient Care Team | 2 | 2019 | 2531 | 0.270 |
Why?
|
Kallikreins | 1 | 2007 | 258 | 0.270 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2006 | 238 | 0.260 |
Why?
|
Administration, Oral | 10 | 2021 | 3913 | 0.260 |
Why?
|
Simuliidae | 1 | 2004 | 4 | 0.250 |
Why?
|
Adrenal Insufficiency | 1 | 2006 | 184 | 0.240 |
Why?
|
Double-Blind Method | 13 | 2021 | 12026 | 0.230 |
Why?
|
Blepharitis | 1 | 2023 | 36 | 0.230 |
Why?
|
Ectropion | 1 | 2023 | 26 | 0.230 |
Why?
|
Epinephrine | 3 | 2019 | 792 | 0.220 |
Why?
|
Quality of Life | 10 | 2023 | 12804 | 0.220 |
Why?
|
Global Warming | 1 | 2023 | 64 | 0.220 |
Why?
|
Male | 70 | 2023 | 350118 | 0.220 |
Why?
|
Practice Guidelines as Topic | 7 | 2022 | 7279 | 0.220 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2018 | 4386 | 0.210 |
Why?
|
Poverty Areas | 1 | 2004 | 275 | 0.210 |
Why?
|
Hypergammaglobulinemia | 2 | 2000 | 74 | 0.210 |
Why?
|
Female | 73 | 2023 | 380194 | 0.210 |
Why?
|
Respiratory Rate | 1 | 2023 | 162 | 0.210 |
Why?
|
Conjunctivitis | 1 | 2023 | 158 | 0.210 |
Why?
|
Evidence-Based Medicine | 3 | 2022 | 3610 | 0.200 |
Why?
|
Hepatitis C | 3 | 1996 | 1591 | 0.200 |
Why?
|
Nucleotide Transport Proteins | 1 | 2021 | 3 | 0.200 |
Why?
|
Th2 Cells | 3 | 2019 | 1061 | 0.200 |
Why?
|
Parent-Child Relations | 1 | 2006 | 747 | 0.200 |
Why?
|
HLA-A2 Antigen | 1 | 2021 | 213 | 0.190 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2408 | 0.190 |
Why?
|
Hepacivirus | 3 | 1996 | 1379 | 0.190 |
Why?
|
Epitope Mapping | 1 | 2021 | 311 | 0.190 |
Why?
|
Attitude to Health | 2 | 2008 | 2052 | 0.180 |
Why?
|
Immune System Diseases | 2 | 2015 | 262 | 0.180 |
Why?
|
X Chromosome | 2 | 2000 | 814 | 0.180 |
Why?
|
Nickel | 1 | 2020 | 130 | 0.170 |
Why?
|
Skin | 4 | 2022 | 4364 | 0.170 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.170 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2013 | 581 | 0.170 |
Why?
|
Bee Venoms | 1 | 2018 | 14 | 0.170 |
Why?
|
Bronchodilator Agents | 2 | 2019 | 502 | 0.160 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2020 | 104 | 0.160 |
Why?
|
Drug Contamination | 2 | 1996 | 147 | 0.160 |
Why?
|
Factor IX | 1 | 1998 | 77 | 0.160 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2006 | 941 | 0.160 |
Why?
|
Anxiety Disorders | 1 | 2009 | 2690 | 0.160 |
Why?
|
Anti-Infective Agents | 2 | 2022 | 972 | 0.160 |
Why?
|
Administration, Cutaneous | 4 | 2023 | 711 | 0.160 |
Why?
|
Hemophilia B | 1 | 1998 | 81 | 0.160 |
Why?
|
STAT1 Transcription Factor | 2 | 2016 | 320 | 0.150 |
Why?
|
Receptors, Interferon | 2 | 2015 | 115 | 0.150 |
Why?
|
Ectodermal Dysplasia | 3 | 2004 | 106 | 0.150 |
Why?
|
Intermediate Filament Proteins | 2 | 2009 | 269 | 0.150 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2018 | 99 | 0.150 |
Why?
|
Herpesvirus 1, Human | 2 | 2021 | 743 | 0.140 |
Why?
|
Administration, Topical | 2 | 2020 | 690 | 0.140 |
Why?
|
Chromatography, Affinity | 1 | 2018 | 549 | 0.140 |
Why?
|
Immunoglobulin M | 2 | 2004 | 1537 | 0.140 |
Why?
|
IgA Deficiency | 2 | 2007 | 43 | 0.140 |
Why?
|
Treatment Outcome | 15 | 2023 | 63114 | 0.140 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2016 | 19 | 0.140 |
Why?
|
Epitopes | 2 | 2021 | 2571 | 0.140 |
Why?
|
Capital Financing | 1 | 2016 | 58 | 0.140 |
Why?
|
Caregivers | 3 | 2023 | 2094 | 0.130 |
Why?
|
Quality Improvement | 3 | 2022 | 3749 | 0.130 |
Why?
|
Epidermolysis Bullosa Acquisita | 1 | 2015 | 13 | 0.130 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 642 | 0.130 |
Why?
|
Eggs | 2 | 2012 | 184 | 0.130 |
Why?
|
Airway Management | 1 | 2019 | 329 | 0.130 |
Why?
|
Hospitalization | 5 | 2023 | 10262 | 0.130 |
Why?
|
Bone Marrow Transplantation | 3 | 2015 | 2765 | 0.130 |
Why?
|
Peptides | 1 | 2007 | 4409 | 0.130 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2017 | 303 | 0.120 |
Why?
|
Antibody Specificity | 2 | 2017 | 1095 | 0.120 |
Why?
|
Steroids | 2 | 1999 | 930 | 0.120 |
Why?
|
Health Promotion | 1 | 2006 | 2205 | 0.120 |
Why?
|
Stress, Psychological | 1 | 2009 | 4245 | 0.120 |
Why?
|
United States | 22 | 2023 | 69872 | 0.120 |
Why?
|
Immunotherapy | 4 | 2018 | 4445 | 0.120 |
Why?
|
HLA-B7 Antigen | 1 | 2013 | 48 | 0.120 |
Why?
|
Disease Management | 2 | 2016 | 2459 | 0.120 |
Why?
|
Ovomucin | 1 | 2013 | 7 | 0.120 |
Why?
|
Patient Care Management | 1 | 2017 | 306 | 0.120 |
Why?
|
Egg White | 1 | 2013 | 18 | 0.120 |
Why?
|
Lymphopenia | 1 | 2016 | 285 | 0.120 |
Why?
|
Consensus | 5 | 2021 | 2959 | 0.110 |
Why?
|
Risk | 6 | 2016 | 9687 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1004 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3870 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 3 | 2004 | 536 | 0.110 |
Why?
|
Antigens, Plant | 3 | 2021 | 86 | 0.110 |
Why?
|
Staphylococcus aureus | 2 | 2022 | 1451 | 0.110 |
Why?
|
Immunologic Factors | 3 | 2021 | 1580 | 0.110 |
Why?
|
Hospitals, Pediatric | 1 | 2022 | 1775 | 0.110 |
Why?
|
Population Groups | 1 | 2013 | 209 | 0.110 |
Why?
|
Eosinophils | 3 | 2019 | 955 | 0.110 |
Why?
|
Leadership | 1 | 2022 | 1357 | 0.110 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2011 | 23 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 3 | 2018 | 1836 | 0.100 |
Why?
|
Plasma | 1 | 2015 | 575 | 0.100 |
Why?
|
Environmental Exposure | 2 | 2020 | 4234 | 0.100 |
Why?
|
Immunization | 5 | 2018 | 1256 | 0.100 |
Why?
|
Adult | 32 | 2022 | 214055 | 0.100 |
Why?
|
B-Lymphocytes | 6 | 2021 | 4665 | 0.100 |
Why?
|
Drug Industry | 1 | 2018 | 746 | 0.100 |
Why?
|
Skin Diseases, Viral | 1 | 2011 | 21 | 0.100 |
Why?
|
Immune Tolerance | 3 | 2017 | 2258 | 0.100 |
Why?
|
Tight Junctions | 2 | 2011 | 311 | 0.100 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2013 | 370 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1405 | 0.100 |
Why?
|
Milk Proteins | 1 | 2012 | 169 | 0.100 |
Why?
|
Cytokines | 3 | 2018 | 7322 | 0.100 |
Why?
|
STAT6 Transcription Factor | 1 | 2011 | 199 | 0.100 |
Why?
|
Health Personnel | 2 | 2016 | 3218 | 0.100 |
Why?
|
Young Adult | 13 | 2021 | 56430 | 0.100 |
Why?
|
Otitis Media | 1 | 1993 | 277 | 0.100 |
Why?
|
Toll-Like Receptor 9 | 1 | 2012 | 212 | 0.100 |
Why?
|
Receptors, IgG | 1 | 2014 | 582 | 0.100 |
Why?
|
Diphtheria Toxoid | 1 | 1990 | 28 | 0.090 |
Why?
|
Receptors, Interleukin-7 | 1 | 2010 | 38 | 0.090 |
Why?
|
Intradermal Tests | 1 | 2010 | 44 | 0.090 |
Why?
|
Administration, Inhalation | 2 | 2006 | 1105 | 0.090 |
Why?
|
Haemophilus Vaccines | 1 | 1990 | 69 | 0.090 |
Why?
|
Injections, Subcutaneous | 4 | 2021 | 666 | 0.090 |
Why?
|
Genotype | 3 | 2021 | 12951 | 0.090 |
Why?
|
Cooking | 1 | 2012 | 313 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 10943 | 0.090 |
Why?
|
Immunologic Memory | 2 | 2018 | 1348 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 9959 | 0.090 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 2 | 2007 | 56 | 0.090 |
Why?
|
Haemophilus influenzae | 1 | 1990 | 171 | 0.090 |
Why?
|
Pigmentation Disorders | 1 | 1990 | 101 | 0.090 |
Why?
|
Dermatology | 1 | 2019 | 872 | 0.090 |
Why?
|
Mutation | 9 | 2021 | 29786 | 0.090 |
Why?
|
Gene Frequency | 5 | 2021 | 3588 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 8 | 2021 | 17446 | 0.090 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 261 | 0.090 |
Why?
|
Sinusitis | 2 | 2000 | 923 | 0.090 |
Why?
|
Primary Prevention | 1 | 2017 | 1167 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2684 | 0.080 |
Why?
|
Progesterone | 1 | 2013 | 776 | 0.080 |
Why?
|
Immunization Schedule | 1 | 2010 | 221 | 0.080 |
Why?
|
Cross Reactions | 1 | 2010 | 841 | 0.080 |
Why?
|
Lymphokines | 1 | 1991 | 949 | 0.080 |
Why?
|
DNA Methylation | 2 | 2019 | 4286 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2021 | 21746 | 0.080 |
Why?
|
Expert Testimony | 1 | 2010 | 356 | 0.080 |
Why?
|
Adrenergic Agonists | 1 | 2008 | 58 | 0.080 |
Why?
|
Pyroglyphidae | 2 | 2022 | 88 | 0.080 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.080 |
Why?
|
Diarrhea | 1 | 2015 | 1348 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7181 | 0.080 |
Why?
|
Bacterial Vaccines | 1 | 1990 | 403 | 0.080 |
Why?
|
Delphi Technique | 2 | 2021 | 778 | 0.080 |
Why?
|
ROC Curve | 3 | 2015 | 3527 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2010 | 1035 | 0.070 |
Why?
|
Polysaccharides, Bacterial | 1 | 1990 | 578 | 0.070 |
Why?
|
Lymphocyte Activation | 3 | 2018 | 5524 | 0.070 |
Why?
|
Immunity, Cellular | 1 | 2013 | 1607 | 0.070 |
Why?
|
Laryngeal Diseases | 1 | 2010 | 241 | 0.070 |
Why?
|
Depression | 1 | 2006 | 7766 | 0.070 |
Why?
|
Patient Care | 1 | 2013 | 640 | 0.070 |
Why?
|
Conjunctivitis, Allergic | 2 | 1998 | 130 | 0.070 |
Why?
|
Health Care Reform | 1 | 2016 | 1261 | 0.070 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1660 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2021 | 7880 | 0.070 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.070 |
Why?
|
Growth | 2 | 1999 | 376 | 0.070 |
Why?
|
Cosyntropin | 1 | 2006 | 33 | 0.070 |
Why?
|
Injections, Intramuscular | 2 | 2019 | 552 | 0.070 |
Why?
|
Larva Migrans, Visceral | 1 | 2006 | 1 | 0.070 |
Why?
|
Oligochaeta | 1 | 2006 | 7 | 0.070 |
Why?
|
Lung Diseases, Parasitic | 1 | 2006 | 14 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 3923 | 0.070 |
Why?
|
Disease Vectors | 1 | 2006 | 60 | 0.070 |
Why?
|
Drug Hypersensitivity | 2 | 2012 | 884 | 0.070 |
Why?
|
Phenotype | 6 | 2023 | 16365 | 0.060 |
Why?
|
Interleukin-13 | 1 | 2007 | 389 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 3479 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 2988 | 0.060 |
Why?
|
CpG Islands | 2 | 2019 | 1172 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2022 | 2309 | 0.060 |
Why?
|
Comorbidity | 2 | 2016 | 10388 | 0.060 |
Why?
|
Boston | 4 | 2022 | 9313 | 0.060 |
Why?
|
Immunophenotyping | 3 | 2018 | 1880 | 0.060 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.060 |
Why?
|
Immunosuppressive Agents | 4 | 2023 | 4149 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2012 | 19229 | 0.060 |
Why?
|
Disease Progression | 3 | 2020 | 13284 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3396 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 3 | 2020 | 1790 | 0.060 |
Why?
|
Long QT Syndrome | 1 | 2008 | 453 | 0.060 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2022 | 12 | 0.060 |
Why?
|
Diet | 2 | 2022 | 7939 | 0.060 |
Why?
|
Hand | 1 | 2008 | 884 | 0.060 |
Why?
|
Infant, Newborn | 6 | 2018 | 25625 | 0.060 |
Why?
|
Pituitary-Adrenal System | 1 | 2006 | 553 | 0.060 |
Why?
|
Leukotriene Antagonists | 1 | 2003 | 127 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 595 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Massachusetts | 2 | 2006 | 8663 | 0.050 |
Why?
|
Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 2872 | 0.050 |
Why?
|
Immunoglobulin A | 2 | 2022 | 992 | 0.050 |
Why?
|
Seed Storage Proteins | 1 | 2021 | 12 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2006 | 703 | 0.050 |
Why?
|
Cellulitis | 1 | 2004 | 206 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7913 | 0.050 |
Why?
|
Pilot Projects | 2 | 2013 | 8324 | 0.050 |
Why?
|
Baths | 1 | 2022 | 54 | 0.050 |
Why?
|
Age of Onset | 2 | 2010 | 3271 | 0.050 |
Why?
|
Antibodies | 3 | 2018 | 2460 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2015 | 15519 | 0.050 |
Why?
|
Acetates | 1 | 2003 | 311 | 0.050 |
Why?
|
2S Albumins, Plant | 1 | 2021 | 28 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2008 | 1063 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2022 | 187 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2016 | 793 | 0.050 |
Why?
|
Animals | 12 | 2022 | 168757 | 0.050 |
Why?
|
Hypotension | 1 | 2008 | 884 | 0.050 |
Why?
|
Adrenergic beta-Agonists | 2 | 2000 | 346 | 0.050 |
Why?
|
Incontinentia Pigmenti | 1 | 2000 | 10 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2010 | 6171 | 0.050 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9274 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39050 | 0.050 |
Why?
|
NF-kappa B | 3 | 2004 | 2499 | 0.050 |
Why?
|
Cohort Studies | 4 | 2023 | 40561 | 0.050 |
Why?
|
Food | 2 | 2016 | 771 | 0.050 |
Why?
|
Patch Tests | 1 | 2020 | 53 | 0.050 |
Why?
|
Peptide Library | 1 | 2021 | 349 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13989 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
Complementary Therapies | 1 | 2004 | 486 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4479 | 0.040 |
Why?
|
Plant Proteins | 1 | 2021 | 364 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2004 | 847 | 0.040 |
Why?
|
Genetic Variation | 2 | 2011 | 6544 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2022 | 2266 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2023 | 696 | 0.040 |
Why?
|
Radioallergosorbent Test | 1 | 1998 | 15 | 0.040 |
Why?
|
Glutathione Transferase | 1 | 2021 | 595 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2015 | 2505 | 0.040 |
Why?
|
Immunoglobulins | 2 | 2017 | 881 | 0.040 |
Why?
|
CD40 Ligand | 1 | 2000 | 526 | 0.040 |
Why?
|
Bees | 1 | 2018 | 43 | 0.040 |
Why?
|
Albuterol | 1 | 1999 | 208 | 0.040 |
Why?
|
Milk | 2 | 2012 | 450 | 0.040 |
Why?
|
Hydrocortisone | 1 | 2006 | 1826 | 0.040 |
Why?
|
Middle Aged | 16 | 2021 | 213383 | 0.040 |
Why?
|
Infant Food | 1 | 1998 | 141 | 0.040 |
Why?
|
Quinolines | 1 | 2003 | 732 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5319 | 0.040 |
Why?
|
Health Surveys | 1 | 2008 | 4037 | 0.040 |
Why?
|
Pollen | 1 | 2018 | 75 | 0.040 |
Why?
|
Photochemical Processes | 1 | 2018 | 84 | 0.040 |
Why?
|
Skin Irritancy Tests | 1 | 2017 | 4 | 0.040 |
Why?
|
Miniaturization | 1 | 2018 | 164 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 2576 | 0.040 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 1997 | 57 | 0.040 |
Why?
|
Drug Dosage Calculations | 1 | 2018 | 114 | 0.040 |
Why?
|
Genome-Wide Association Study | 3 | 2021 | 12261 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2017 | 370 | 0.040 |
Why?
|
Dietetics | 1 | 2017 | 35 | 0.040 |
Why?
|
Family | 1 | 2008 | 3147 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2017 | 117 | 0.040 |
Why?
|
I-kappa B Kinase | 3 | 2004 | 252 | 0.040 |
Why?
|
Influenza B virus | 1 | 2017 | 50 | 0.040 |
Why?
|
Eating | 2 | 2019 | 1536 | 0.040 |
Why?
|
Hepatitis, Chronic | 1 | 1996 | 52 | 0.040 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2017 | 90 | 0.040 |
Why?
|
Nurse Practitioners | 1 | 2019 | 270 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1676 | 0.030 |
Why?
|
Hepatitis C Antibodies | 1 | 1996 | 145 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3597 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4328 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 1997 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2017 | 220 | 0.030 |
Why?
|
Leukotrienes | 1 | 1997 | 255 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2005 | 2564 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2019 | 417 | 0.030 |
Why?
|
Nutritional Sciences | 1 | 2017 | 137 | 0.030 |
Why?
|
Phosphorylation | 3 | 2016 | 8436 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
Cattle | 2 | 2012 | 3922 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2019 | 3647 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8340 | 0.030 |
Why?
|
Fear | 1 | 2004 | 1440 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2017 | 169 | 0.030 |
Why?
|
Risk Factors | 6 | 2018 | 72290 | 0.030 |
Why?
|
Keratinocytes | 2 | 2011 | 798 | 0.030 |
Why?
|
Emergency Medical Services | 2 | 2021 | 1917 | 0.030 |
Why?
|
Exons | 3 | 2013 | 2437 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 950 | 0.030 |
Why?
|
Prospective Studies | 3 | 2012 | 53288 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 1995 | 255 | 0.030 |
Why?
|
Myocarditis | 1 | 2002 | 771 | 0.030 |
Why?
|
Immunoassay | 1 | 2018 | 752 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 40075 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.030 |
Why?
|
Haplotypes | 2 | 2011 | 2779 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 1996 | 592 | 0.030 |
Why?
|
Recombinant Proteins | 4 | 1998 | 6622 | 0.030 |
Why?
|
Sulfamethoxazole | 1 | 1993 | 53 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 1995 | 245 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12959 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1147 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 866 | 0.030 |
Why?
|
Trimethoprim | 1 | 1993 | 91 | 0.030 |
Why?
|
Rural Population | 1 | 2004 | 2210 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1799 | 0.030 |
Why?
|
Mothers | 1 | 2004 | 2165 | 0.030 |
Why?
|
Viremia | 1 | 1996 | 736 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2971 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1547 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2107 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2017 | 459 | 0.030 |
Why?
|
Research | 1 | 2021 | 1999 | 0.030 |
Why?
|
Interleukin-2 | 3 | 2002 | 1904 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 2013 | 315 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15076 | 0.030 |
Why?
|
Reference Standards | 1 | 2016 | 1025 | 0.030 |
Why?
|
Ovalbumin | 1 | 2014 | 719 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2016 | 13815 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2012 | 38 | 0.030 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2012 | 86 | 0.030 |
Why?
|
Basophils | 1 | 2014 | 389 | 0.030 |
Why?
|
Antibodies, Viral | 2 | 2017 | 3176 | 0.030 |
Why?
|
Health Behavior | 1 | 2004 | 2636 | 0.030 |
Why?
|
Concanavalin A | 1 | 1991 | 191 | 0.030 |
Why?
|
Cockroaches | 1 | 2012 | 96 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2022 | 1439 | 0.030 |
Why?
|
Seasons | 1 | 2018 | 1493 | 0.030 |
Why?
|
Killer Cells, Natural | 2 | 2016 | 2133 | 0.030 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1411 | 0.020 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12245 | 0.020 |
Why?
|
Genetic Association Studies | 2 | 2011 | 2703 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2016 | 2256 | 0.020 |
Why?
|
Cocos | 1 | 2010 | 7 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2015 | 1547 | 0.020 |
Why?
|
Logistic Models | 2 | 2015 | 13408 | 0.020 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 372 | 0.020 |
Why?
|
Vaccinia | 1 | 2011 | 76 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 1681 | 0.020 |
Why?
|
Smallpox Vaccine | 1 | 2011 | 80 | 0.020 |
Why?
|
Cats | 1 | 2012 | 998 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 29063 | 0.020 |
Why?
|
Prevalence | 3 | 2013 | 15226 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 821 | 0.020 |
Why?
|
Age Factors | 3 | 2017 | 18370 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5255 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9734 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7149 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1584 | 0.020 |
Why?
|
Self Care | 1 | 2015 | 786 | 0.020 |
Why?
|
Chemokine CCL27 | 1 | 2009 | 2 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1125 | 0.020 |
Why?
|
Chemokine CCL17 | 1 | 2009 | 23 | 0.020 |
Why?
|
Hair Color | 1 | 1990 | 136 | 0.020 |
Why?
|
Vaccinia virus | 1 | 2011 | 349 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3019 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2012 | 551 | 0.020 |
Why?
|
Alleles | 1 | 2000 | 6933 | 0.020 |
Why?
|
Gene Expression | 2 | 2016 | 7799 | 0.020 |
Why?
|
Home Care Services | 1 | 2015 | 606 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2000 | 7785 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.020 |
Why?
|
Chemokine CXCL10 | 1 | 2009 | 304 | 0.020 |
Why?
|
Pedigree | 2 | 2000 | 4644 | 0.020 |
Why?
|
Food Labeling | 1 | 2011 | 178 | 0.020 |
Why?
|
Herpesvirus 2, Human | 1 | 2009 | 189 | 0.020 |
Why?
|
Simplexvirus | 1 | 2011 | 802 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2012 | 873 | 0.020 |
Why?
|
RNA, Viral | 1 | 1996 | 2902 | 0.020 |
Why?
|
Interferon-beta | 1 | 2009 | 323 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2010 | 4186 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6489 | 0.020 |
Why?
|
Dogs | 1 | 2012 | 3912 | 0.020 |
Why?
|
Syndrome | 2 | 1990 | 3251 | 0.020 |
Why?
|
Mast Cells | 1 | 2014 | 1544 | 0.020 |
Why?
|
Hot Temperature | 1 | 2012 | 1354 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2012 | 14557 | 0.020 |
Why?
|
Edema | 1 | 2010 | 789 | 0.020 |
Why?
|
Pharmacokinetics | 1 | 2006 | 88 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 1997 | 2219 | 0.020 |
Why?
|
Infection Control | 1 | 1993 | 966 | 0.020 |
Why?
|
Influenza, Human | 1 | 2017 | 1479 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 1990 | 1041 | 0.020 |
Why?
|
Antibody Formation | 1 | 1990 | 1402 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11366 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9438 | 0.020 |
Why?
|
Mice | 4 | 2012 | 81183 | 0.020 |
Why?
|
Forced Expiratory Volume | 2 | 2003 | 1743 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1990 | 1470 | 0.010 |
Why?
|
Cell Division | 1 | 1991 | 4568 | 0.010 |
Why?
|
Mycobacterium Infections | 1 | 2004 | 119 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6386 | 0.010 |
Why?
|
Sulfides | 1 | 2003 | 165 | 0.010 |
Why?
|
Nutritional Status | 1 | 2011 | 1609 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
Lymphocytes | 1 | 1990 | 2617 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2003 | 446 | 0.010 |
Why?
|
Cyclopropanes | 1 | 2003 | 416 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1990 | 4776 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5974 | 0.010 |
Why?
|
Giant Cells | 1 | 2002 | 187 | 0.010 |
Why?
|
Physicians | 1 | 2019 | 4567 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10180 | 0.010 |
Why?
|
Medication Adherence | 1 | 2012 | 2063 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9849 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15997 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9146 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5078 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3336 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6895 | 0.010 |
Why?
|
Neutrophils | 1 | 2012 | 3719 | 0.010 |
Why?
|
Quality of Health Care | 1 | 1995 | 4371 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7659 | 0.010 |
Why?
|
Drug Synergism | 1 | 2003 | 1792 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1226 | 0.010 |
Why?
|
Ligands | 1 | 2005 | 3282 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2000 | 641 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2006 | 1401 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 57776 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1990 | 7722 | 0.010 |
Why?
|
Rats | 1 | 2012 | 24260 | 0.010 |
Why?
|
Receptors, Interleukin-4 | 1 | 1995 | 65 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23338 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1995 | 192 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2000 | 2421 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11483 | 0.010 |
Why?
|
Cromolyn Sodium | 1 | 1995 | 87 | 0.010 |
Why?
|
Nebulizers and Vaporizers | 1 | 1995 | 139 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21827 | 0.010 |
Why?
|
Genetic Testing | 1 | 2007 | 3444 | 0.010 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1993 | 141 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3846 | 0.010 |
Why?
|
Immunoglobulin Class Switching | 1 | 1995 | 291 | 0.010 |
Why?
|
Up-Regulation | 1 | 2002 | 4217 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25043 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12072 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3494 | 0.010 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 1990 | 150 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1993 | 1588 | 0.010 |
Why?
|
Medically Uninsured | 1 | 1995 | 853 | 0.010 |
Why?
|
Base Sequence | 1 | 2000 | 12797 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18111 | 0.010 |
Why?
|
Prednisone | 1 | 1993 | 1574 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2002 | 3110 | 0.010 |
Why?
|
Incidence | 1 | 2006 | 20947 | 0.000 |
Why?
|
Treatment Failure | 1 | 1993 | 2618 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 3772 | 0.000 |
Why?
|
Reference Values | 1 | 1990 | 4982 | 0.000 |
Why?
|
Insurance, Health | 1 | 1995 | 2494 | 0.000 |
Why?
|
Medicaid | 1 | 1995 | 2736 | 0.000 |
Why?
|
Interleukin-6 | 1 | 1990 | 3200 | 0.000 |
Why?
|
Antigens, CD | 1 | 1990 | 4026 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1990 | 3386 | 0.000 |
Why?
|